We are live on ! Find out more
CG

CFO4Life Group Portfolio holdings

AUM $656M
1-Year Est. Return 17.88%
This Fund
S&P 500
This Quarter Est. Return
-1.77%
1 Year Est. Return
+17.88%
3 Year Est. Return
+43.38%
5 Year Est. Return
+49.69%
10 Year Est. Return
AUM
$430M
AUM Growth
-$3.67M
Cap. Flow
+$6.62M
Cap. Flow %
1.54%
Top 10 Hldgs %
59.68%
Holding
154
New
13
Increased
94
Reduced
19
Closed
12

Sector Composition

Rank Sector Weight
1 Industrials 17.21%
2 Technology 10.12%
3 Consumer Staples 9.28%
4 Financials 6.19%
5 Consumer Discretionary 4.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PGR icon
151
Progressive
PGR
$123B
-6,512
Closed -$640K
PH icon
152
Parker-Hannifin
PH
$123B
-2,102
Closed -$645K
PSX icon
153
Phillips 66
PSX
$84.9B
-2,579
Closed -$221K
WSM icon
154
Williams-Sonoma
WSM
$26.9B
-9,002
Closed -$719K

Similar funds

CFO4Life Group's Q3 2021 Portfolio in Review

As of Q3 2021, CFO4Life Group held 154 positions worth $430M, down 0.85% from $433M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

CFO4Life Group's Q3 2021 filing shows 13 new, 94 increased, 19 reduced and 12 closed positions. Its largest new stake was Target: 3,332 shares worth $762K. The largest sale was Darling Ingredients, an estimated $3.96M.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Staples.

  • CFO4Life Group's largest Q3 2021 buy was Target: 3,332 shares worth $762K.
  • CFO4Life Group added most to Vanguard S&P 500 ETF in Q3 2021, an estimated $2.1M increase.
  • CFO4Life Group's biggest Q3 2021 reduction was Darling Ingredients, cutting an estimated $3.96M.
  • CFO4Life Group fully exited 3M in Q3 2021, selling an estimated $2.7M.
  • CFO4Life Group's ten largest holdings make up 60% of its $430M portfolio in Q3 2021.
  • CFO4Life Group opened 13 new positions and closed 12 in Q3 2021.
  • CFO4Life Group's portfolio value fell 0.85% quarter-over-quarter to $430M.

Based on CFO4Life Group's 13F filing for Q3 2021, filed 12 Oct 2021.